Bioseek offers human primary cell systems to bridge the gap from biochemistry and molecular biology to preclinical in vivo models and clinical observations, arriving at richer insights to advance compounds through development.
March 8
BIOSEEK LAUNCHES ITS DIVERSITY 8 PANEL AT THE SOCIETY OF…
BIOMAP® SYSTEMS DIFFERENTIATES AUTOIMMUNE TARGETS, IDENTIFIES POTENTIAL FOR SELECTIVE DRUGS
November 8
DISCOVERX CORPORATION ACQUIRES BIOSEEK
October 4
BioSeek Awarded New Five-Year Contract from EPA ToxCast™ Program
August 6
New BioMAP® Systems Website
March 12
Insights into Toxicity of Nanomaterials, Failed Drugs and Environmental Chemicals